MM-249 KRAS, NRAS, BRAF Genes Mutations in the Tumor Substrate from Bone Marrow, ctDNA and Plasmacytomas in Multiple Myeloma (MM)Maya Soloveva, Л. П. Менделеева, Maxim Solovev et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0
Efficacy of second autologous stem cell transplantation in patients with multiple myelomaЛ. П. Менделеева, S. M. Kulikov, A. A. Startsev et al.|Oncohematology|2025Cited by 0
Kidney damage in patients with multiple myeloma associated with light chain deposition disease and C3 glomerulopathyAnastasia V. Popova, Л. П. Менделеева, M. V. Solovev et al.|Oncohematology|2025Cited by 0
<i>KRAS</i>, <i>NRAS</i>, <i>BRAF</i> genes mutations in tumor cells of various localizations and their impact on the treatment outcomes of patients with multiple myelomaMaya Soloveva, Л. П. Менделеева, A. B. Sudarikov et al.|Oncohematology|2025Cited by 0